Nvidia-backed AI drugmaker Iambic Therapeutics has filed for a US initial public offering
Business – 3 outlets
Bloomberg
Novo CEO Says Drugmaker Has More to Do to Win Over Investors
Novo CEO Says Drugmaker Has More to Do to Win Over Investors Opens in new window seen
Nvidia-Backed AI Drugmaker Iambic Therapeutics Files for IPO Opens in new window seen
Nvidia-Backed AI Drugmaker Iambic Therapeutics Files for IPO
CNBC
Novo CEO signals M&A opportunities to strengthen drug pipeline
Washington Examiner
Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing